Rick Ornelas from Novalar Pharmaceuticals discusses Oraverse, a new local anesthetic reversing agent.
Flap mentioned OraVerse last Fall and now it is available. Watch the video above for the sales pitch.
Dental patient information is here.
Information for dentists is here.
As I said at the time:"Flap sees a limited applicability for this drug since the mandibular block most associated with lower lip and tongue numbness is growing out of favor for most routine dental procedures anyway. Plus, there are some shorter acting dental anesthetics that can be used as well.
However, there are some patients who will have extensive procedures who may wish to return their soft tissues to normal quicker - e.g business. On the other hand, increased duration of anesthesia is desirable for patient comfort.
Flap bets the drug will be marketed for use in children over the age of 6 or 7 and adolescents so they will not have an opportunity to chew their lip."
Technorati Tags: OraVerse
No comments:
Post a Comment